Literature DB >> 15120256

Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.

Peter M Smith-Jones1, David B Solit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120256     DOI: 10.1016/S0076-6879(04)86012-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  5 in total

1.  Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.

Authors:  Muthu Ramakrishnan; Thomas M Wengenack; Karunya K Kandimalla; Geoffry L Curran; Emily J Gilles; Marina Ramirez-Alvarado; Joseph Lin; Michael Garwood; Clifford R Jack; Joseph F Poduslo
Journal:  Pharm Res       Date:  2008-04-29       Impact factor: 4.200

2.  Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts.

Authors:  Sean Carlin; Nahida Khan; Thomas Ku; Valerie A Longo; Steve M Larson; Peter M Smith-Jones
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

3.  Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Authors:  David B Solit; S Percy Ivy; Catherine Kopil; Rachel Sikorski; Michael J Morris; Susan F Slovin; W Kevin Kelly; Anthony DeLaCruz; Tracy Curley; Glenn Heller; Steven Larson; Lawrence Schwartz; Merrill J Egorin; Neal Rosen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

4.  Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.

Authors:  Volkan Beylergil; Patrick G Morris; Peter M Smith-Jones; Shanu Modi; David Solit; Clifford A Hudis; Yang Lu; Joseph O'Donoghue; Serge K Lyashchenko; Jorge A Carrasquillo; Steven M Larson; Timothy J Akhurst
Journal:  Nucl Med Commun       Date:  2013-12       Impact factor: 1.690

5.  Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

Authors:  Carlos Pérez-Medina; Dalya Abdel-Atti; Jun Tang; Yiming Zhao; Zahi A Fayad; Jason S Lewis; Willem J M Mulder; Thomas Reiner
Journal:  Nat Commun       Date:  2016-06-20       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.